Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Plasma Administration”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00089011
What this trial is testing

Tacrolimus and Mycophenolate Mofetil in Preventing Graft-Versus-Host Disease in Patients Who Have Undergone Total-Body Irradiation With or Without Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant for Hematologic Cancer

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+171 more
Fred Hutchinson Cancer Center 150
Not applicableStudy completedNCT04797377
What this trial is testing

Autologous Intraovarian Platelet Rich Plasma Treatment in Women With Poor Ovarian Response

Who this might be right for
Poor Ovarian Reserve
Nadezhda Women's Health Hospital 66
Early research (Phase 1)Active Not RecruitingNCT05981209
What this trial is testing

Elotuzumab, CC-92480, and Dexamethasone for the Treatment of Relapsed or Refractory Myeloma After CD38- and BCMA-Targeted Therapies

Who this might be right for
Recurrent Multiple MyelomaRefractory Multiple Myeloma
Abdullah Khan 12
Testing effectiveness (Phase 2)Active Not RecruitingNCT04439175
What this trial is testing

Testing GDC-0032 (Taselisib) as a Potential Targeted Treatment in Cancers With PIK3CA Genetic Changes (MATCH-Subprotocol I)

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm+3 more
National Cancer Institute (NCI) 70
Early research (Phase 1)Ended earlyNCT04405167
What this trial is testing

Tasquinimod for the Treatment of Relapsed or Refractory Myeloma

Who this might be right for
Multiple Myeloma
University of Pennsylvania 30
Early research (Phase 1)Study completedNCT01258751
What this trial is testing

This Study Will Evaluate The Relationship Between Plasma Drug Levels And Receptor Binding In Brain Using PET (Positron Emission Tomography) In Healthy Volunteers

Who this might be right for
Healthy
Pfizer 12
Not applicableStudy completedNCT03046329
What this trial is testing

Improving the Quality of Multiple Myeloma Treatment With Patient Care Plans

Who this might be right for
Multiple Myeloma
Carevive Systems, Inc. 90
Early research (Phase 1)Study completedNCT01318902
What this trial is testing

Study of Oral Ixazomib in Adult Participants With Relapsed or Refractory Light Chain Amyloidosis

Who this might be right for
Light-Chain Amyloidosis
Millennium Pharmaceuticals, Inc. 27
Large-scale testing (Phase 3)Not Yet RecruitingNCT07735637
What this trial is testing

A Phase III, Multicentre Study to Evaluate Consolidation Treatment With AZD0120 Compared With ASCT, in Participants With Newly Diagnosed Multiple Myeloma Who Are Transplant Eligible (DURGA-6).

Who this might be right for
Newly Diagnosed Multiple Myeloma (NDMM)
AstraZeneca 750
Testing effectiveness (Phase 2)WithdrawnNCT00003605
What this trial is testing

Rituximab Plus Cyclophosphamide in Treating Patients With Indolent Stage III or Stage IV Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Hoag Memorial Hospital Presbyterian
Testing effectiveness (Phase 2)UnknownNCT04321629
What this trial is testing

Knee Arthritis Treatment With Autologous Fragmented Adipose Tissue and PRP - Comparison of Two Treatment Methods

Who this might be right for
Osteo Arthritis KneeKnee OsteoarthritisKnee Pain Chronic+4 more
Rehasport Clinic 60
Early research (Phase 1)Ended earlyNCT00800150
What this trial is testing

Total Marrow and Total Lymph Node Irradiation, Fludarabine, and Melphalan Followed By Donor Stem Cell Transplant in Treating Patients With Advanced Hematological Cancer That Has Not Responded to Treatment

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+3 more
City of Hope Medical Center 6
Testing effectiveness (Phase 2)UnknownNCT05749133
What this trial is testing

Safety and Efficacy of Anti-GPRC5D CAR-T Cells Therapy in the Treatment of r/r MM

Who this might be right for
Multiple Myeloma in RelapseMultiple Myeloma, Refractory
XuYan 18
Testing effectiveness (Phase 2)Active Not RecruitingNCT06390826
What this trial is testing

Testing Sunitinib as Potentially Targeted Treatment in Cancers With cKIT Genetic Changes (MATCH - Subprotocol V)

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmRefractory Lymphoma+2 more
National Cancer Institute (NCI) 10
Large-scale testing (Phase 3)Study completedNCT02548338
What this trial is testing

Argon Plasma Coagulation Scalpel on Surgical Treatment of Breast Cancer

Who this might be right for
Breast Neoplasms
Federal University of São Paulo 60
Testing effectiveness (Phase 2)Temporarily pausedNCT05563948
What this trial is testing

Repeated Administration of Cannabis Varying in THC and CBD

Who this might be right for
Cannabis
New York State Psychiatric Institute 100
Testing effectiveness (Phase 2)Study completedNCT00313625
What this trial is testing

Melphalan and Busulfan Followed By Donor Peripheral Stem Cell Transplant, Tacrolimus, and Methotrexate in Treating Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Fred Hutchinson Cancer Center 20
Large-scale testing (Phase 3)Ended earlyNCT01445197
What this trial is testing

Study of Biostate for Treatment of Children With Hemophilia A Complicated by Antibody Development

Who this might be right for
Hemophilia A
CSL Behring 1
Testing effectiveness (Phase 2)Study completedNCT04433910
What this trial is testing

A Clinical Trial of Convalescent Plasma Compared to Best Supportive Care for Treatment of Patients With Severe COVID-19

Who this might be right for
COVID-19
Deutsches Rotes Kreuz DRK-Blutspendedienst Baden-Wurttemberg-Hessen 106
Large-scale testing (Phase 3)Study completedNCT02419118
What this trial is testing

"Monoclonal Antibodies for Treatment of Multiple Myeloma. Emphasis on the CD38 Antibody Daratumumab "

Who this might be right for
Multiple Myeloma
Vejle Hospital 4
Next Page